This invention relates to compounds of Formula I having the following general structure:
and pharmaceutically acceptable salts thereof which are inhibitors of the Renal Outer Medullary Potassium (ROMK) channel (Kir1.1). The compounds are useful as diuretics and natriuretics and therefore are useful for the therapy and prophylaxis of disorders resulting from excessive salt and water retention, including cardiovascular diseases such as hypertension and chronic and acute heart failure.
本发明涉及具有以下一般结构的I型化合物及其药学上可接受的盐,这些化合物是肾外髓质
钾通道(Kir1.1)的
抑制剂。这些化合物可用作利尿剂和排
钠剂,因此可用于治疗和预防由过多的盐和
水潴留引起的疾病,包括心血管疾病如高血压和慢性和急性心力衰竭。